Effects of Exercise Intervention and Rehabilitation Exercise Intervention in Patients With Type 2 Diabetes
NCT ID: NCT01393275
Last Updated: 2011-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2010-02-28
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* to determine if a supervised exercise intervention is improving the metabolic parameters in type 2 diabetes patients
* to investigate what kind of intervention (strength endurance training versus combined strength endurance training and rehabilitation exercise intervention)is more effective in improving the metabolic parameters in patients with type 2 diabetes
* to assess which exercise intervention induces higher effects to the metabolic rate and cardiac and pulmonary capacity
* to investigate what kind of intervention includes highest effects in long term persistence of these positive effects
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rehabilitation intervention group
The group is performing a strength endurance training intervention in addition with rehabilitation exercise intervention.
rehabilitation exercise intervention
exercise intervention: 15 minutes warm up, 30 minutes strength endurance training, 60 minutes rehabilitation exercise training - once a week
15 minutes warm up, 30 minutes strength endurance training - once a week
Placebo rehabilitation
The group is performing a strength endurance training intervention in addition with placebo rehabilitation exercise intervention.
placebo control group
exercise intervention: 15 minutes warm up, 30 minutes strength endurance training, 5 minutes walking 55 minutes conversation in the group- once a week
15 minutes warm up, 30 minutes strength endurance training - once a week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rehabilitation exercise intervention
exercise intervention: 15 minutes warm up, 30 minutes strength endurance training, 60 minutes rehabilitation exercise training - once a week
15 minutes warm up, 30 minutes strength endurance training - once a week
placebo control group
exercise intervention: 15 minutes warm up, 30 minutes strength endurance training, 5 minutes walking 55 minutes conversation in the group- once a week
15 minutes warm up, 30 minutes strength endurance training - once a week
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted diabetes treatment will be diet and oral hypoglycemic agents
Exclusion Criteria
medical conditions
* proliferative retinopathy
* instable coronary heart disease
* acute clinically significant intercurrent disease
* inability to perform scheduled physical activity programs
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sportpark Zwickau, Germany
UNKNOWN
Sportpark Glauchau, Germany
UNKNOWN
Comenius University
OTHER
University of Giessen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andree Hillebrecht
Akad. Rat
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andree Hillebrecht, Dr. med.
Role: STUDY_CHAIR
University of Giessen
Dusan Hamar, Prof. Dr.
Role: STUDY_DIRECTOR
Comenius University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Giessen
Giessen, Hesse, Germany
Sportpark Zwickau, Glauchau, Meerane
Zwickau, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Gi-01-2010
Identifier Type: -
Identifier Source: org_study_id